Compare DLR & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLR | BDX |
|---|---|---|
| Founded | 2004 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.6B | 54.6B |
| IPO Year | 2004 | 1998 |
| Metric | DLR | BDX |
|---|---|---|
| Price | $183.79 | $208.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 34 | 16 |
| Target Price | ★ $224.22 | $195.57 |
| AVG Volume (30 Days) | ★ 2.1M | 1.5M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.71% | 2.12% |
| EPS Growth | ★ 122.36 | N/A |
| EPS | 0.46 | ★ 1.59 |
| Revenue | $6,112,692,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $20.01 | N/A |
| Revenue Next Year | $11.13 | $2.27 |
| P/E Ratio | $390.30 | ★ $123.85 |
| Revenue Growth | ★ 10.04 | 8.24 |
| 52 Week Low | $146.23 | $140.11 |
| 52 Week High | $208.14 | $213.08 |
| Indicator | DLR | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 52.43 | 63.10 |
| Support Level | $179.08 | $175.60 |
| Resistance Level | $184.62 | $200.47 |
| Average True Range (ATR) | 5.06 | 3.56 |
| MACD | 0.85 | 0.23 |
| Stochastic Oscillator | 69.24 | 79.05 |
Digital Realty is one of the leading providers of cloud- and carrier-neutral data centers, offering colocation and interconnection services to hyperscalers and large businesses. Digital Realty operates 300 properties in 57 metropolitan areas across 31 countries, serving 5,000 customers. Renting physical space accounts for about 90% of Digital Realty's revenue. The firm enables hyperscalers and other clients to store servers, data, and networking equipment. The other 10% of revenue is generated primarily through interconnection services (8%) and other fee income (2%).
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.